170 related articles for article (PubMed ID: 21175567)
1. Anti-angiogenic effects of two cystine-knot miniproteins from tomato fruit.
Cavallini C; Trettene M; Degan M; Delva P; Molesini B; Minuz P; Pandolfini T
Br J Pharmacol; 2011 Mar; 162(6):1261-73. PubMed ID: 21175567
[TBL] [Abstract][Full Text] [Related]
2. A cystine-knot miniprotein from tomato fruit inhibits endothelial cell migration and angiogenesis by affecting vascular endothelial growth factor receptor (VEGFR) activation and nitric oxide production.
Treggiari D; Zoccatelli G; Molesini B; Degan M; Rotino GL; Sala T; Cavallini C; MacRae CA; Minuz P; Pandolfini T
Mol Nutr Food Res; 2015 Nov; 59(11):2255-66. PubMed ID: 26255647
[TBL] [Abstract][Full Text] [Related]
3. Tomato cystine-knot miniproteins possessing anti-angiogenic activity exhibit in vitro gastrointestinal stability, intestinal absorption and resistance to food industrial processing.
Treggiari D; Zoccatelli G; Chignola R; Molesini B; Minuz P; Pandolfini T
Food Chem; 2017 Apr; 221():1346-1353. PubMed ID: 27979099
[TBL] [Abstract][Full Text] [Related]
4. Plant cystine-knot peptides: pharmacological perspectives.
Molesini B; Treggiari D; Dalbeni A; Minuz P; Pandolfini T
Br J Clin Pharmacol; 2017 Jan; 83(1):63-70. PubMed ID: 26987851
[TBL] [Abstract][Full Text] [Related]
5. Biochemical and MALDI-TOF Mass Spectrometric Characterization of a Novel Native and Recombinant Cystine Knot Miniprotein from Solanum tuberosum subsp. andigenum cv. Churqueña.
Cotabarren J; Tellechea ME; Tanco SM; Lorenzo J; Garcia-Pardo J; Avilés FX; Obregón WD
Int J Mol Sci; 2018 Feb; 19(3):. PubMed ID: 29495576
[TBL] [Abstract][Full Text] [Related]
6. Combinatorial optimization of cystine-knot peptides towards high-affinity inhibitors of human matriptase-1.
Glotzbach B; Reinwarth M; Weber N; Fabritz S; Tomaszowski M; Fittler H; Christmann A; Avrutina O; Kolmar H
PLoS One; 2013; 8(10):e76956. PubMed ID: 24146945
[TBL] [Abstract][Full Text] [Related]
7. Anti-angiogenic and vascular disrupting effects of C9, a new microtubule-depolymerizing agent.
Ren X; Dai M; Lin LP; Li PK; Ding J
Br J Pharmacol; 2009 Apr; 156(8):1228-38. PubMed ID: 19302593
[TBL] [Abstract][Full Text] [Related]
8. NSK-01105, a novel sorafenib derivative, inhibits human prostate tumor growth via suppression of VEGFR2/EGFR-mediated angiogenesis.
Yu P; Ye L; Wang H; Du G; Zhang J; Zuo Y; Zhang J; Tian J
PLoS One; 2014; 9(12):e115041. PubMed ID: 25551444
[TBL] [Abstract][Full Text] [Related]
9. Synthetic Cystine-Knot Miniproteins - Valuable Scaffolds for Polypeptide Engineering.
Avrutina O
Adv Exp Med Biol; 2016; 917():121-44. PubMed ID: 27236555
[TBL] [Abstract][Full Text] [Related]
10. Targeting tumor angiogenesis with histone deacetylase inhibitors: the hydroxamic acid derivative LBH589.
Qian DZ; Kato Y; Shabbeer S; Wei Y; Verheul HM; Salumbides B; Sanni T; Atadja P; Pili R
Clin Cancer Res; 2006 Jan; 12(2):634-42. PubMed ID: 16428510
[TBL] [Abstract][Full Text] [Related]
11. Anti-angiogenic properties of a sulindac analogue.
Pyriochou A; Tsigkos S; Vassilakopoulos T; Cottin T; Zhou Z; Gourzoulidou E; Roussos C; Waldmann H; Giannis A; Papapetropoulos A
Br J Pharmacol; 2007 Dec; 152(8):1207-14. PubMed ID: 17965739
[TBL] [Abstract][Full Text] [Related]
12. Isogambogenic acid inhibits tumour angiogenesis by suppressing Rho GTPases and vascular endothelial growth factor receptor 2 signalling pathway.
Fan Y; Peng A; He S; Shao X; Nie C; Chen L
J Chemother; 2013 Oct; 25(5):298-308. PubMed ID: 24070138
[TBL] [Abstract][Full Text] [Related]
13. Anti-angiogenic effect of quercetin and its 8-methyl pentamethyl ether derivative in human microvascular endothelial cells.
Lupo G; Cambria MT; Olivieri M; Rocco C; Caporarello N; Longo A; Zanghì G; Salmeri M; Foti MC; Anfuso CD
J Cell Mol Med; 2019 Oct; 23(10):6565-6577. PubMed ID: 31369203
[TBL] [Abstract][Full Text] [Related]
14. A novel 2-aminobenzimidazole-based compound Jzu 17 exhibits anti-angiogenesis effects by targeting VEGFR-2 signalling.
Lien JC; Chung CL; Huang TF; Chang TC; Chen KC; Gao GY; Hsu MJ; Huang SW
Br J Pharmacol; 2019 Oct; 176(20):4034-4049. PubMed ID: 31368127
[TBL] [Abstract][Full Text] [Related]
15. Anti-angiogenic activity of the flavonoid precursor 4-hydroxychalcone.
Varinska L; van Wijhe M; Belleri M; Mitola S; Perjesi P; Presta M; Koolwijk P; Ivanova L; Mojzis J
Eur J Pharmacol; 2012 Sep; 691(1-3):125-33. PubMed ID: 22721615
[TBL] [Abstract][Full Text] [Related]
16. Cyclopeptide RA-V inhibits angiogenesis by down-regulating ERK1/2 phosphorylation in HUVEC and HMEC-1 endothelial cells.
Yue GG; Fan JT; Lee JK; Zeng GZ; Ho TW; Fung KP; Leung PC; Tan NH; Lau CB
Br J Pharmacol; 2011 Dec; 164(7):1883-98. PubMed ID: 21518338
[TBL] [Abstract][Full Text] [Related]
17. PE, a new sulfated saponin from sea cucumber, exhibits anti-angiogenic and anti-tumor activities in vitro and in vivo.
Tian F; Zhang X; Tong Y; Yi Y; Zhang S; Li L; Sun P; Lin L; Ding J
Cancer Biol Ther; 2005 Aug; 4(8):874-82. PubMed ID: 16082187
[TBL] [Abstract][Full Text] [Related]
18. Therapeutic concentrations of digitoxin inhibit endothelial focal adhesion kinase and angiogenesis induced by different growth factors.
Trenti A; Zulato E; Pasqualini L; Indraccolo S; Bolego C; Trevisi L
Br J Pharmacol; 2017 Sep; 174(18):3094-3106. PubMed ID: 28688145
[TBL] [Abstract][Full Text] [Related]
19. Allotides: Proline-Rich Cystine Knot α-Amylase Inhibitors from Allamanda cathartica.
Nguyen PQ; Luu TT; Bai Y; Nguyen GK; Pervushin K; Tam JP
J Nat Prod; 2015 Apr; 78(4):695-704. PubMed ID: 25832441
[TBL] [Abstract][Full Text] [Related]
20. Morelloflavone, a biflavonoid, inhibits tumor angiogenesis by targeting rho GTPases and extracellular signal-regulated kinase signaling pathways.
Pang X; Yi T; Yi Z; Cho SG; Qu W; Pinkaew D; Fujise K; Liu M
Cancer Res; 2009 Jan; 69(2):518-25. PubMed ID: 19147565
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
